Transaction in Own Shares

Petershill Partners PLC
28 March 2024
 

Transactions in own shares

 

Date of purchase: 27 March 2024

Aggregate number of ordinary shares purchased: 100

Lowest price paid per share GBp 188.00

Highest price per share GBp 190.20

Average price per share GBp 189.60

 

The company intends to cancel the purchased shares.

 

Since 17 May 2023, the Company has purchased 15,819,602 shares at a cost (including dealing and associated costs) of $31,757,799.10 (£25,257,218.63).

 

Following the above transaction, the company holds 0 of its ordinary shares in treasury and has 1,119,579,995 ordinary shares in issue (excluding treasury shares and any shares purchased by the Company through Merrill Lynch International which are yet to be cancelled).

 

Schedule of Purchases

Shares purchased: (ISIN: GB00BL9ZF303 | LEI: 213800HTCF8A7XM22A32)

Date of purchases: 27 March 2024

Investment Firm: Merrill Lynch International

 

Enquiries to

Petershill Partners plc

Gurjit Kambo

Head of Investor Relations

+44 (0) 7454 750 709

 

 

Aggregate information:

 

Venue

Volume-weighted average price (GBp)

Aggregated volume

Lowest price per share (GBp)

Highest price per share (GBp)

London Stock Exchange

189.60

100

188.00

190.20

Cboe BXE

0.00

0

0.00

0.00

Cboe CXE

0.00

0

0.00

0.00

Aquis

0.00

0

0.00

0.00

Turquoise

0.00

0

0.00

0.00

 

 

The schedule accessible via the following link contains detailed and aggregated information of the individual trades made by Merrill Lynch International as part of the buyback programme:

 

 

 

Detailed Purchases:

Transaction Date

Transaction Time

Volume

Price (GBp)

Platform

Transaction Reference Number

27-Mar-24

09:11:05

26

190.00

XLON

0XL091100000000088VQ6K

27-Mar-24

09:11:05

26

190.20

XLON

0XL091100000000088VQ6J

27-Mar-24

09:11:05

28

189.80

XLON

0XL091100000000088VQ6L

27-Mar-24

09:55:01

20

188.00

XLON

0XL091100000000088VRKJ

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings